227 related articles for article (PubMed ID: 17520870)
1. PGE synthase inhibitors as an alternative to COX-2 inhibitors.
Jachak SM
Curr Opin Investig Drugs; 2007 May; 8(5):411-5. PubMed ID: 17520870
[TBL] [Abstract][Full Text] [Related]
2. Prostanoids and inflammatory pain.
Chen L; Yang G; Grosser T
Prostaglandins Other Lipid Mediat; 2013; 104-105():58-66. PubMed ID: 22981510
[TBL] [Abstract][Full Text] [Related]
3. Characterization of microsomal prostaglandin E synthase 1 inhibitors.
Korotkova M; Jakobsson PJ
Basic Clin Pharmacol Toxicol; 2014 Jan; 114(1):64-9. PubMed ID: 24138533
[TBL] [Abstract][Full Text] [Related]
4. Membrane prostaglandin E synthase-1: a novel therapeutic target.
Samuelsson B; Morgenstern R; Jakobsson PJ
Pharmacol Rev; 2007 Sep; 59(3):207-24. PubMed ID: 17878511
[TBL] [Abstract][Full Text] [Related]
5. Prostaglandin E2 synthesis and secretion: the role of PGE2 synthases.
Park JY; Pillinger MH; Abramson SB
Clin Immunol; 2006 Jun; 119(3):229-40. PubMed ID: 16540375
[TBL] [Abstract][Full Text] [Related]
6. Distinction of microsomal prostaglandin E synthase-1 (mPGES-1) inhibition from cyclooxygenase-2 inhibition in cells using a novel, selective mPGES-1 inhibitor.
Mbalaviele G; Pauley AM; Shaffer AF; Zweifel BS; Mathialagan S; Mnich SJ; Nemirovskiy OV; Carter J; Gierse JK; Wang JL; Vazquez ML; Moore WM; Masferrer JL
Biochem Pharmacol; 2010 May; 79(10):1445-54. PubMed ID: 20067770
[TBL] [Abstract][Full Text] [Related]
7. Prostaglandin E(2) synthase inhibition as a therapeutic target.
Iyer JP; Srivastava PK; Dev R; Dastidar SG; Ray A
Expert Opin Ther Targets; 2009 Jul; 13(7):849-65. PubMed ID: 19530988
[TBL] [Abstract][Full Text] [Related]
8. Inhibitors of the microsomal prostaglandin E(2) synthase-1 as alternative to non steroidal anti-inflammatory drugs (NSAIDs)--a critical review.
Koeberle A; Werz O
Curr Med Chem; 2009; 16(32):4274-96. PubMed ID: 19754418
[TBL] [Abstract][Full Text] [Related]
9. Microsomal prostaglandin E synthase-1 inhibition in cardiovascular inflammatory disease.
Wang M; Song WL; Cheng Y; Fitzgerald GA
J Intern Med; 2008 May; 263(5):500-5. PubMed ID: 18410593
[TBL] [Abstract][Full Text] [Related]
10. Microsomal prostaglandin E2 synthase: a safer target than cyclooxygenases?
Timmers L; Pasterkamp G; de Kleijn DP
Mol Interv; 2007 Aug; 7(4):195-9, 180. PubMed ID: 17827439
[TBL] [Abstract][Full Text] [Related]
11. Prostaglandin E2 is an enhancer of interleukin-1beta-induced expression of membrane-associated prostaglandin E synthase in rheumatoid synovial fibroblasts.
Kojima F; Naraba H; Sasaki Y; Beppu M; Aoki H; Kawai S
Arthritis Rheum; 2003 Oct; 48(10):2819-28. PubMed ID: 14558087
[TBL] [Abstract][Full Text] [Related]
12. Microparticles stimulate the synthesis of prostaglandin E(2) via induction of cyclooxygenase 2 and microsomal prostaglandin E synthase 1.
Jüngel A; Distler O; Schulze-Horsel U; Huber LC; Ha HR; Simmen B; Kalden JR; Pisetsky DS; Gay S; Distler JH
Arthritis Rheum; 2007 Nov; 56(11):3564-74. PubMed ID: 17968936
[TBL] [Abstract][Full Text] [Related]
13. Engineering of a novel hybrid enzyme: an anti-inflammatory drug target with triple catalytic activities directly converting arachidonic acid into the inflammatory prostaglandin E2.
Ruan KH; Cervantes V; So SP
Protein Eng Des Sel; 2009 Dec; 22(12):733-40. PubMed ID: 19850676
[TBL] [Abstract][Full Text] [Related]
14. Paracetamol effectively reduces prostaglandin E2 synthesis in brain macrophages by inhibiting enzymatic activity of cyclooxygenase but not phospholipase and prostaglandin E synthase.
Greco A; Ajmone-Cat MA; Nicolini A; Sciulli MG; Minghetti L
J Neurosci Res; 2003 Mar; 71(6):844-52. PubMed ID: 12605411
[TBL] [Abstract][Full Text] [Related]
15. Perspective of microsomal prostaglandin E2 synthase-1 as drug target in inflammation-related disorders.
Koeberle A; Werz O
Biochem Pharmacol; 2015 Nov; 98(1):1-15. PubMed ID: 26123522
[TBL] [Abstract][Full Text] [Related]
16. Characterization of a new mPGES-1 inhibitor in rat models of inflammation.
Leclerc P; Pawelzik SC; Idborg H; Spahiu L; Larsson C; Stenberg P; Korotkova M; Jakobsson PJ
Prostaglandins Other Lipid Mediat; 2013; 102-103():1-12. PubMed ID: 23528231
[TBL] [Abstract][Full Text] [Related]
17. Curcumin blocks prostaglandin E2 biosynthesis through direct inhibition of the microsomal prostaglandin E2 synthase-1.
Koeberle A; Northoff H; Werz O
Mol Cancer Ther; 2009 Aug; 8(8):2348-55. PubMed ID: 19671757
[TBL] [Abstract][Full Text] [Related]
18. Dual acting anti-inflammatory drugs: a reappraisal.
Bertolini A; Ottani A; Sandrini M
Pharmacol Res; 2001 Dec; 44(6):437-50. PubMed ID: 11735348
[TBL] [Abstract][Full Text] [Related]
19. [Development of anti-inflammatory drugs targeted against prostaglandin-related molecules].
Sato T; Nakajima T; Yamano Y
Nihon Rinsho; 2010 Oct; 68(10):1835-9. PubMed ID: 20954326
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of inducible prostaglandin E(2) synthase by 15-deoxy-Delta(12,14)-prostaglandin J(2) and polyunsaturated fatty acids.
Quraishi O; Mancini JA; Riendeau D
Biochem Pharmacol; 2002 Mar; 63(6):1183-9. PubMed ID: 11931852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
